U.S. Medical Polymers Market Size & Outlook, 2022-2030
U.S. medical polymers market, 2019-2030 (US$M)
Related Markets
U.S. medical polymers market highlights
- The U.S. medical polymers market generated a revenue of USD 6,929.0 million in 2022 and is expected to reach USD 12,860.5 million by 2030.
- The U.S. market is expected to grow at a CAGR of 8% from 2023 to 2030.
- In terms of segment, fibers & resins was the largest revenue generating product in 2022.
- Biodegradable Polymers is the most lucrative product segment registering the fastest growth during the forecast period.
Medical polymers market data book summary
| Market revenue in 2022 | USD 6,929.0 million |
| Market revenue in 2030 | USD 12,860.5 million |
| Growth rate | 8% (CAGR from 2022 to 2030) |
| Largest segment | Fibers & resins |
| Fastest growing segment | Biodegradable Polymers |
| Historical data | 2019 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Fibers & Resins, Medical Elastomers, Biodegradable Polymers |
| Key market players worldwide | Basf SE, Cargill, Covestro AG, Celanese Corp Class A, Eastman Chemical Co, Evonik Industries AG, Dow Inc, Exxon Mobil Corp, Arkema SA, Koninklijke DSM NV, Formosa Plastics Group, SABIC, Trinseo PLC |
Other key industry trends
- In terms of revenue, U.S. accounted for 34.8% of the global medical polymers market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. medical polymers market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 12,860.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Medical Polymers Market Scope
Medical Polymers Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. medical polymers market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to medical polymers market will help companies and investors design strategic landscapes.
Fibers & resins was the largest segment with a revenue share of 63.79% in 2022. Horizon Databook has segmented the U.S. medical polymers market based on fibers & resins, medical elastomers, biodegradable polymers covering the revenue growth of each sub-segment from 2019 to 2030.
The presence of key governmental initiatives such as Affordable Care Act (ACA) and Medicaid has enabled a large percentage of the population to gain access to healthcare facilities and services in the U.S.
This has boosted the demand for branded drugs, medical devices, and healthcare services, thereby driving the need for medical polymers in the country, primarily in applications such as medical components, packaging, and wound care.
Use of hormone therapy for the treatment of menopausal symptoms elevate estrogen levels, which is one of the major causes of breast cancer in women. Mastectomy performed to treat breast cancer is expected to create more demand for silicone breast implants, which, in turn, is expected to drive the growth of the market for medical polymers in the coming years.
Reasons to subscribe to U.S. medical polymers market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. medical polymers market databook
-
Our clientele includes a mix of medical polymers market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. medical polymers market , including forecasts for subscribers. This country databook contains high-level insights into U.S. medical polymers market from 2019 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. medical polymers market size, by product, 2019-2030 (US$M)
U.S. Medical Polymers Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
